T1D Exchange Revenue and Competitors

Claim your profile

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • T1D Exchange's estimated annual revenue is currently $15.1M per year.(i)
  • T1D Exchange's estimated revenue per employee is $243,000

Employee Data

  • T1D Exchange has 62 Employees.(i)
  • T1D Exchange grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.7M31N/AN/AN/A
#2
$2.3M14N/AN/AN/A
#3
$107M3170%N/AN/A
#4
$776.8M20559%N/AN/A
#5
$557.9M1476-2%N/AN/A
#6
$1.9M12N/AN/AN/A
#7
$42.5M143N/AN/AN/A
#8
$623.7M16501%N/AN/A
#9
$0.8M6N/AN/AN/A
#10
$1498.8M39654%N/AN/A

T1D Exchange is a nonprofit research organization dedicated to accelerating therapies and improving care for people affected by type 1 diabetes. T1D Exchange actively supports discovery and innovationparticularly at its earliest stages. At the same time, the organization understands that laboratory breakthroughs are not enough. Evidence gathered in the real world is necessary to help bridge the gap between discovery in research settings and impact in people's lives. The T1D Exchange model uses cutting-edge research tools, methods and programs to gather evidence from the real-world and clinical experiences of people living with type 1 diabetes. Visit our online community for people with type 1 diabetes at myglu.org. Follow us on Twitter: - @t1dexchange Follow us on Facebook: - http://www.facebook.com/myglu

keywords:Biotechnology,Healthcare,Healthcare Providers,Pharmaceuticals

N/A

Total Funding

62

Number of Employees

$15.1M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

T1D Exchange News

2016-10-06 - T1D Exchange pledges to invest millions in automated insulin delivery

Boston-based nonprofit T1D Exchange has announced its intentions to make a multi-million dollar investment in automated insulin delivery technologies, the smart algorithms that serve as the bridge between CGMs and insulin pumps in the quest to create an artificial pancreas. “Type 1 diabetes is ...

2021-06-25 - New T1D Exchange Data at American Diabetes Association 81st Scientific Sessions Highlight Patient Care Inequities

BOSTON, June 25, 2021 /PRNewswire/ -- T1D Exchange, a nonprofit organization that drives meaningful research and innovation in treatment of type 1 diabetes (T1D), today announced that new real-world data from both its Quality Improvement Collaborative (QIC) and its online patient Registry will ...

08/14/2019 - Type 1 Diabetes Often Misdiagnosed in Adults and Children

Results of a survey of 2526 participants recruited from the T1D Exchange clinic and online communities were published in the July 2019 issue ...

08/14/2019 - Type 1 Diabetes Misdiagnosed in One-Fourth of Children, Adults

Cynthia Munoz, Ph.D., from the University of Southern California in Los Angeles, and colleagues used data from the T1D Exchange clinic ...

08/16/2019 - Medtronic receives FDA investigational approval for testing of ...

... with that of standard devices in 150 adults with type 1 diabetes aged ... Medtronic, Merck, NIDDK, Novo Nordisk, Sanofi and T1D Exchange.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.3M6255%$32.3M
#2
N/A629%N/A
#3
$10M62-16%N/A
#4
$15.1M62N/AN/A
#5
$11.7M62N/AN/A